PDE9A anticorps (AA 1-186)
Aperçu rapide pour PDE9A anticorps (AA 1-186) (ABIN1885730)
Antigène
Voir toutes PDE9A AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1-186
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 1 and 186 of Human PDE9A
-
-
-
-
Indications d'application
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunohistochemistry: 1.50-1.500 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- PDE9A (phosphodiesterase 9A (PDE9A))
-
Autre désignation
- Phosphodiesterase 9A
-
Sujet
-
The protein encoded by this gene catalyzes the hydrolysis of cAMP and cGMP to their corresponding monophosphates.The encoded protein plays a role in signal transduction by regulating the intracellular concentration of these cyclic nucleotides.Multiple transcript variants encoding several different isoforms have been found for this gene.[provided by RefSeq]
-
Poids moléculaire
- 69 kDa
-
ID gène
- 5152
-
NCBI Accession
- NM_002606, NP_002597
Antigène
-